Moxonidin Ratiopharm (Moxonidine)

• Moxonidine acts on central imidazoline I1 receptors to control high blood pressure.
• Hypertension: reduces elevated blood pressure in patients with primary hypertension.

• Moxonidine selectively stimulates central imidazoline I1 receptors, which diminishes sympathetic outflow from the brainstem. This reduction in sympathetic activity leads to decreased peripheral vascular resistance and lower cardiac output, resulting in a modest decline in arterial blood pressure.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dry mouth: reduced salivary flow causing discomfort.
• Fatigue: feeling unusually tired or weak.
• Dizziness: light‑headed sensation, especially when standing.
• Headache: mild to moderate pain in the head region.
• Nausea: upset stomach or urge to vomit.
• Constipation: infrequent or difficult bowel movements.

Serious or Rare Side Effects

• Severe hypotension: markedly low blood pressure requiring medical attention.
• Bradycardia: abnormally slow heart rate.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Liver enzyme elevation: abnormal liver function tests.
• Cardiac conduction abnormalities: heart block or arrhythmias.
• Syncope: sudden loss of consciousness.

Before prescribing Moxonidin Ratiopharm, clinicians should consider several safety aspects.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Renal impairment: adjust dose or monitor closely in patients with reduced kidney function.
• Cardiovascular disease: use caution in patients with ischemic heart disease or heart failure.
• Abrupt discontinuation: taper gradually to prevent rebound hypertension.
• Contraindications: avoid in patients with known hypersensitivity to moxonidine.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Moxonidin Ratiopharm can interact with other medicines that affect blood pressure or the central nervous system.

Major Interactions (Avoid)

• Other central antihypertensives (e.g., clonidine, guanfacine): may cause additive hypotensive effects.
• Monoamine oxidase inhibitors: risk of severe blood pressure changes.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance the blood‑pressure‑lowering effect, requiring dose adjustment.

• Beta‑blockers: combined use may increase risk of bradycardia.
• NSAIDs: can blunt the antihypertensive response, necessitating closer monitoring.